These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 23583246)

  • 1. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.
    Bartunek J; Behfar A; Dolatabadi D; Vanderheyden M; Ostojic M; Dens J; El Nakadi B; Banovic M; Beleslin B; Vrolix M; Legrand V; Vrints C; Vanoverschelde JL; Crespo-Diaz R; Homsy C; Tendera M; Waldman S; Wijns W; Terzic A
    J Am Coll Cardiol; 2013 Jun; 61(23):2329-38. PubMed ID: 23583246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study.
    Teerlink JR; Metra M; Filippatos GS; Davison BA; Bartunek J; Terzic A; Gersh BJ; Povsic TJ; Henry TD; Alexandre B; Homsy C; Edwards C; Seron A; Wijns W; Cotter G;
    Eur J Heart Fail; 2017 Nov; 19(11):1520-1529. PubMed ID: 28560782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of cardiopoietic stem cells in the treatment of post-infarction left-ventricular dysfunction - From cardioprotection to functional repair in a translational pig infarction model.
    Emmert MY; Wolint P; Jakab A; Sheehy SP; Pasqualini FS; Nguyen TDL; Hilbe M; Seifert B; Weber B; Brokopp CE; Macejovska D; Caliskan E; von Eckardstein A; Schwartlander R; Vogel V; Falk V; Parker KK; Gyöngyösi M; Hoerstrup SP
    Biomaterials; 2017 Apr; 122():48-62. PubMed ID: 28107664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
    Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
    Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
    Bartunek J; Terzic A; Davison BA; Filippatos GS; Radovanovic S; Beleslin B; Merkely B; Musialek P; Wojakowski W; Andreka P; Horvath IG; Katz A; Dolatabadi D; El Nakadi B; Arandjelovic A; Edes I; Seferovic PM; Obradovic S; Vanderheyden M; Jagic N; Petrov I; Atar S; Halabi M; Gelev VL; Shochat MK; Kasprzak JD; Sanz-Ruiz R; Heyndrickx GR; Nyolczas N; Legrand V; Guédès A; Heyse A; Moccetti T; Fernandez-Aviles F; Jimenez-Quevedo P; Bayes-Genis A; Hernandez-Garcia JM; Ribichini F; Gruchala M; Waldman SA; Teerlink JR; Gersh BJ; Povsic TJ; Henry TD; Metra M; Hajjar RJ; Tendera M; Behfar A; Alexandre B; Seron A; Stough WG; Sherman W; Cotter G; Wijns W;
    Eur Heart J; 2017 Mar; 38(9):648-660. PubMed ID: 28025189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
    Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
    Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design.
    Bartunek J; Davison B; Sherman W; Povsic T; Henry TD; Gersh B; Metra M; Filippatos G; Hajjar R; Behfar A; Homsy C; Cotter G; Wijns W; Tendera M; Terzic A
    Eur J Heart Fail; 2016 Feb; 18(2):160-8. PubMed ID: 26662998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply: The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE).
    Bartunek J; Behfar A; Dolatabadi D; Vanderheyden M; Ostojic M; Dens J; El Nakadi B; Banovic M; Beleslin B; Vrolix M; Legrand V; Vrints C; Vanoverschelde JL; Crespo-Diaz R; Homsy C; Tendera M; Waldman S; Wijns W; Terzic A
    J Am Coll Cardiol; 2013 Dec; 62(25):2454-2456. PubMed ID: 24355591
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE).
    Mielewczik M; Cole GD; Nowbar AN; Schilling R; Whinnett ZI; Bordachar P; Wilmshurst P; Chambers JC; Olshansky B; Morgan J; Israel C; Sethi AS; van Houwelingen M; Cleland JG; Schmidt G; Francis DP
    J Am Coll Cardiol; 2013 Dec; 62(25):2453. PubMed ID: 24355589
    [No Abstract]   [Full Text] [Related]  

  • 11. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction.
    Lee ST; White AJ; Matsushita S; Malliaras K; Steenbergen C; Zhang Y; Li TS; Terrovitis J; Yee K; Simsir S; Makkar R; Marbán E
    J Am Coll Cardiol; 2011 Jan; 57(4):455-65. PubMed ID: 21251587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
    Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart failUre PaTiEnts Trial.
    Mazzaferri EL; Gradinac S; Sagic D; Otasevic P; Hasan AK; Goff TL; Sievert H; Wunderlich N; Nikolic SD; Abraham WT
    Am Heart J; 2012 May; 163(5):812-820.e1. PubMed ID: 22607859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial.
    Heeger CH; Jaquet K; Thiele H; Zulkarnaen Y; Cuneo A; Haller D; Kivelitz D; Schmidt T; Krause K; Metzner A; Schneider C; Kuck KH; Bergmann MW
    EuroIntervention; 2012 Oct; 8(6):732-42. PubMed ID: 23086792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of elastic restraint to lessen the effects of heart failure (PEERLESS-HF) trial.
    Costanzo MR; Ivanhoe RJ; Kao A; Anand IS; Bank A; Boehmer J; Demarco T; Hergert CM; Holcomb RG; Maybaum S; Sun B; Vassiliades TA; Rayburn BK; Abraham WT
    J Card Fail; 2012 Jun; 18(6):446-58. PubMed ID: 22633302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy.
    Gao LR; Wang ZG; Zhu ZM; Fei YX; He S; Tian HT; Zhang NK; Chen Y; Xu HT; Yang Y
    Am J Cardiol; 2006 Sep; 98(5):597-602. PubMed ID: 16923443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.